IMUX earnings: a negative outcome, -9.2%

On February 24, 2022, IMMUNIC, INC. reached its earnings. The result was a negative outcome, and the stock moved -9.2% in the window around the event. It had already run +18.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.